KMO and acute kidney injury: Together, these data convincingly demonstrate that 3-hydroxykynurenine production by KMO is a significant contributor to AKI following renal IRI, and reinforce the concept of KMO inhibition as a protective strategy to protect against organ dysfunction in critical illness.